His lab is working on refining the alanine-scanning assay to some vital residues which will precisely distinguish among fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological diagnosis, And perhaps for blood screening of tauopathies.Within the La Biennale di Venezia Web page: “He